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INTRODUCTION 
 
• Fluorescent Nuclear Track Detectors (FNTDs) (Fig. 1) are based on 
biocompatible single aluminium oxide crystals doped with carbon 
and magnesium (Al2O3; C,Mg). 
 
FNTDs 
 
• Because FNTDs are grown in a highly reduced atmosphere, 
they contain high concentration of clustered oxygen vacancy 
defects charge compensated by magnesium ions substituting 
aluminium ions in the crystal lattice (Fig. 2). 
 
EXPERIMENT 1: Range measurements 
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Fig. 1 Size of a FNTD compared 
 to a one cent coin 
• Implanted detectors or detectors in body cavities can help 
accessing direct information on a radiation treatment such as ion 
fluences, energies or ranges.  
 
• We therefore measured ion ranges for particle beams of low and 
clinical fluence in order to investigate the feasibility of future in-
vivo FNTD applications. 
• Their superior spatial resolution 
allows for monitoring single 
particle tracks with a detection 
efficiency close to 100% for ions 
with LET greater than 
approximately 0.2 keV μm  [1]. 
• Depicted F2
2+ 2Mg  colour centres undergo radiochromic 
transformation under ionising radiation (Fig. 3) by capturing 
secondary electrons: F2
2+ 2Mg + e− ⟶ F2
+ 2Mg . 
Fig. 2 Crystal structure of corundum (left) and model of an aggregate oxygen vacancy 
defect (right); image courtesy of M.S. Akselrod (Landauer Inc.) [2] 
                Before doping: Al2O3                         After doping: Al2O3;C,Mg 
      FNTDs before,                             during                         and after irradiation. 
Fig. 3 FNTD containing only untransformed colour centres (left); liberation and capture of 
secondary electrons under ionising irradiation (middle); radiochromic transformation (right) 
• Untransformed F2
2+ 2Mg  (light blue) and untransformed 
F2
+ 2Mg  colour centres (light red) have different absorption and 
emission bands (Fig. 4) which can be stimulated using confocal 
microscopy. 
Fig. 4 Absorption and 
fluorescence of untransformed 
(left) and transformed colour 
centres; commercial confocal 
laser-scanning microscopy 
allows for fast and non-
destructive detector readout; 
image courtesy of M.S. 
Akselrod (Landauer Inc.) [3] 
high quantum yield 
and short lifetime 
(𝝉 = 𝟕𝟓 ± 𝟓 𝐧𝐬) [1]  
Fig. 5 Comparison of carbon irradiated FNTDs; theoretical SRIM range of 33.05 μm [4] at a total kinetic beam energy of 48 MeV 
𝟑. 𝟏 × 𝟏𝟎𝟔 𝐜𝐦−𝟐 𝟑. 𝟏 × 𝟏𝟎𝟕 𝐜𝐦−𝟐 1. 𝟎 × 𝟏𝟎𝟗 𝐜𝐦−𝟐 1. 𝟎 × 𝟏𝟎𝟏𝟎 𝐜𝐦−𝟐 1. 𝟎 × 𝟏𝟎𝟏𝟏 𝐜𝐦−𝟐 
• Single track evaluation (𝚽 < 𝟏𝟎𝟕 𝐜𝐦−𝟐):  determine entrance and end point 
individually for each particle track yielding projected range and lateral straggling; 
time-consuming but precise measurement routine 
 
• Track bulk evaluation (𝚽 > 𝟏𝟎𝟕 𝐜𝐦−𝟐):  determine inflection points in 
corresponding intensity profiles yielding projected range only; fast and automated 
measurement routine with the same level of precision (pinhole reduction advised for 
very high particle fluences) 
 
Fig. 6 Results of the high-accuracy ion range measurements for 
mono-energetic particle beams of various ion sources; all 
deviations from theory below 3% 
   C-12 FNTDs were irradiated with mono-energetic  ions using a broad range of particle types (hydrogen to 
xenon), kinetic energies, and particle fluences Φ (from 4.5 × 105 up to 1.0 × 1011 cm−2) (Fig. 5). FNTD 
FNTDs were homogeneously irradiated 
with 50 MeV u  to establish a dose-
fluorescence relation for this treatment 
modality (Fig. 7, Fig. 8). 
Fig. 8 (right) 
Correlation 
between 
absorbed dose 
and 
fluorescence 
strength; 
obtained by 
taking the 
mean grey 
values of the 
images from 
figure seven 
All measured ranges deviate less than 3% from tabulated SRIM data [4] (Fig. 6). 
Measurement accuracy does not show any significant dependency on ion type, 
energy, fluence or LET. 
FNTDs were placed in a PMMA 
cylinder as a phantom undergoing 
clinical workflow. Based on computed 
tomography (CT) scans, a treatment 
plan (applying 1 Gy protons at the 
detector edge) was created at HIT 
(Fig 9). The planned depth-dose 
curve at 80 % was compared to the 
detected intensity profile. 
Fig. 7 (left) 
Comparison of 
proton irradiated 
FNTDs sorted by 
increasing particle 
fluence 
𝟏𝟎𝟔 𝐜𝐦−𝟐 𝟏𝟎𝟕 𝐜𝐦−𝟐 𝟏𝟎𝟖 𝐜𝐦−𝟐 
𝟏𝟎𝟗 𝐜𝐦−𝟐 𝟏𝟎𝟏𝟎 𝐜𝐦−𝟐 
    
FNTD 
p 
Fig. 9 Results of the treatment plan verification: optimized 
dose distribution in the PMMA cylinder and the detector volume 
(black box) (top left); detected intensity distribution (bottom); 
comparison of planned depth-dose curve and detected intensity 
profile (top right). The equidistant minima seen in the intensity 
profile (Fig. 9) originate from microscope vignetting 
    p 
p     
FNTD 
Detected and expected 
range agree within 
limiting CT slice 
thickness of 1 mm.  
 
Correlating fluorescence 
strength and absorbed 
dose verifies the 
maximal planned dose.   
 
FNTDs appear as 
potential fiducial marks 
in the CT. 
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EXPERIMENT 2: 
Absorbed dose measurements 
Therapeutic treatment plans 
can be verified using FNTDs  by 
(a) comparing ranges and 
(b) correlating intensity and 
dose. 
EXPERIMENT 3: Treatment plan verification 
